JUNS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Jupiter Neurosciences Inc (JUNS) is not a strong buy for a beginner, long-term investor at this time. Despite a positive pre-market price change of 5.86%, the lack of significant trading trends, neutral technical indicators, no recent news, and weak financial performance make it unsuitable for long-term investment. The stock lacks strong positive catalysts and has no clear signals from proprietary trading tools.
The MACD histogram is positive at 0.0111 but contracting, RSI is neutral at 36.926, and moving averages are converging, indicating no clear trend. Support is at 0.363, resistance at 0.48, with a pivot at 0.422. Overall, technical indicators suggest a neutral outlook.
Pre-market price change of 5.86%.
No significant trading trends from hedge funds or insiders. No recent news or event-driven catalysts. Weak financial performance with negative net income and EPS, despite YoY improvements.
In Q4 2025, revenue remained flat at 21,796. Net income improved YoY but remains negative at -2,575,031. EPS increased by 40% YoY but is still negative at -0.07. Gross margin is strong at 80.59%, but overall financials are weak for long-term investment.
No analyst rating or price target changes available.
